Seed VC · USA
The fund invests in private biotechnology companies across stage, modality, therapeutic area, and geography, with a mission to identify and support innovative companies that can shape the future of patient treatment while utilizing collective experience to guide portfolio companies toward successful outcomes.
Business models
deeptech_ip, biotech_therapeutics
Customer segments
Researchers
Geography
US
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
JP Morgan Private Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks JP Morgan Private Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. JP Morgan Private Capital is one of them — and we'll tell you exactly where they sit in your top 100.